These Healthcare stocks are trading higher:
-Equillium Inc (EQ) stock is trading at $1.19, a gain of $0.38, or 46.62%, on high volume. Equillium Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.50.
-Tenax Therapeutics Inc (TENX) stock is trading at $11.80, a gain of $3.06, or 41.06%, on high volume. Tenax Therapeutics gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $440.00. Tenax Therapeutics next reports earnings on February 12.
-Immunome Inc (IMNM) stock is trading at $22.25, a rise of $5.37, or 31.81%, on high volume. Immunome Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $19.00.
-Karyopharm Therapeutics Inc (KPTI) stock is trading at $1.74, an increase of $0.39, or 28.89%, on high volume. Karyopharm Therapeut gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.00. Karyopharm Therapeut next reports earnings on February 21.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-BioRestorative Therapies Inc (BRTX) stock is trading at $1.55, a loss of $1.9, or 54.77%, on high volume. Biorestorative Therapies Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $12.50. Biorestorative Therapies Inc next reports earnings on February 12.
-Akso Health Group - ADR (AHG) stock is trading at $1.71, a drop of $0.53, or 23.66%, on average volume. Akso Health Group ADR gets a Sentiment Score of Neutral from InvestorsObserver.
-Revelation Biosciences Inc (REVB) stock is trading at $2.65, a drop of $0.55, or 17.19%, on moderate volume. Revelation Biosciences Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $343.84. Revelation Biosciences Inc next reports earnings on February 7.
-Immix Biopharma Inc (IMMX) stock is trading at $2.52, a decline of $0.5, or 16.47%, on high volume. Immix Biopharma Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $14.00.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
